Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 10Head and Neck Neoplasms 7Radiodermatitis 5Lymphedema 5Stomatitis 4Neoplasms 4Radiation Injuries 3Ulcer 2Mucositis 2Fibrosis 2Dermatitis 2Xerostomia 1Wounds and Injuries 1Trismus 1Squamous Cell Carcinoma of Head and Neck 1Skin Diseases 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Eczema 1Breast Cancer Lymphedema 1

Interventions

Paclitaxel 177Carboplatin 177Bevacizumab 72Topotecan 55liposomal doxorubicin 54Gemcitabine 53Cisplatin 46Docetaxel 39Cyclophosphamide 37olaparib 32Filgrastim 31pembrolizumab 29Doxorubicin 26niraparib 24Taxes 23Drug Therapy 23Peripheral Blood Stem Cell Transplantation 20Etoposide 17veliparib 15Nivolumab 14sargramostim 13Surveys and Questionnaires 13Immunoglobulin G 13Disulfides 13pazopanib 12Ifosfamide 12Albumin-Bound Paclitaxel 12durvalumab 11atezolizumab 11Trabectedin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ovarian Neoplasms × Low-Level Light Therapy × Clear all
NCT02000908 2019-02-11

Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy

University of Minnesota

Phase NA Completed
70 enrolled 6 charts
Gynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡